Publications
5491 Results
- Journal / Conference
- Journal of Comparative Effectiveness Research Dec;11(18):1313-1321
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36378570
- PMC
- PMC9832319
- Study Number(s)
- S1415CD
An Evaluation of Stakeholder Engagement in Comparative Effectiveness Research: Lessons Learned from SWOG S1415CD
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention Nov 2;31(11):2063-2069
- Year
- 2022
- Research Committee(s)
- Prevention and Epidemiology
- PMID
- PMID36084322
- PMC
- PMC9756313
- Study Number(s)
- S0000
Differential Biopsy Patterns Influence Associations Between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial
- Journal / Conference
- Journal of Clinical Oncology Oct 26;JCO2102371. doi: 10.1200/JCO.21.02371. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID36288512
- Study Number(s)
- CTSU/A071401
Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations
- Journal / Conference
- JAMA Oncology Sep 1;8(9):1263-1270. doi: 10.1001/jamaoncol.2022.2319
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID35834226
- PMC
- PMC9284408
- Study Number(s)
- CTSU/A021501
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial
- Journal / Conference
- Society for Clinical Trials (MAY 15-18, 2022 San Diego, CA), oral
- Year
- 2022
- Research Committee(s)
- Breast
- Study Number(s)
- S0500
The application of ACCEPT software in retrospective analysis of specimen data (SWOG S0500 Translational Medicine Project)
- Journal / Conference
- Journal of Clinical Oncology Dec 20;40(36):4240-4249
- Year
- 2022
- PMID
- PMID35867947
- PMC
- PMC9916043
A Phase II Study of Enzalutamide for Patients with Androgen Receptor Positive Salivary Gland Cancers (Alliance A091404)
- Journal / Conference
- American Statistical Society Meeting, oral
- Year
- 2022
- Research Committee(s)
- Multiple sites
A dynamic mapping tool for Spatial-Temporal data: Visualizing data for patients registered to a national cancer clinical trials network
- Journal / Conference
- ASTRO Annual Meeting (October 23 - 26, 2022, San Antonio, TX), oral
- Year
- 2022
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1806
INTACT (S/N1806): Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer. Toxicity update on first 213 patients
- Journal / Conference
- International Journal of Radiation Oncology, Biology, PhysicsVol. 114Issue 3SupplementS43Published in issue: November 01, 2022; ASTRO Annual Meeting (October 23 - 26, 2022, San Antonio, TX), oral scientific session
- Year
- 2022
- Research Committee(s)
- Breast
- Study Number(s)
- S1007
Radiotherapy use and locoregional recurrence rates on SWOG S1007
- Journal / Conference
- ASTRO Annual Meeting (October 23 - 26, 2022, San Antonio, TX), oral
- Year
- 2022
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1404